Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Incidence of milrinone blood levels outside the therapeutic range and their relevance in children after cardiac surgery for congenital heart disease.

Garcia Guerra G, Joffe AR, Senthilselvan A, Kutsogiannis DJ, Parshuram CS.

Intensive Care Med. 2013 May;39(5):951-7. doi: 10.1007/s00134-013-2858-3. Epub 2013 Feb 22.

PMID:
23435950
2.

Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.

Lechner E, Hofer A, Leitner-Peneder G, Freynschlag R, Mair R, Weinzettel R, Rehak P, Gombotz H.

Pediatr Crit Care Med. 2012 Sep;13(5):542-8. doi: 10.1097/PCC.0b013e3182455571.

PMID:
22622649
3.

Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics.

Hoffman TM, Wernovsky G, Atz AM, Bailey JM, Akbary A, Kocsis JF, Nelson DP, Chang AC, Kulik TJ, Spray TL, Wessel DL.

Am Heart J. 2002 Jan;143(1):15-21.

PMID:
11773907
4.

A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery.

Bailey JM, Hoffman TM, Wessel DL, Nelson DP, Atz AM, Chang AC, Kulik TJ, Spray TL, Akbary A, Miller RP, Wernovsky G.

J Pharmacokinet Pharmacodyn. 2004 Feb;31(1):43-59.

PMID:
15346851
5.

Relation of milrinone after surgery for congenital heart disease to significant postoperative tachyarrhythmias.

Smith AH, Owen J, Borgman KY, Fish FA, Kannankeril PJ.

Am J Cardiol. 2011 Dec 1;108(11):1620-4. doi: 10.1016/j.amjcard.2011.07.023. Epub 2011 Sep 3.

6.

Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery.

Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL.

Crit Care Med. 1995 Nov;23(11):1907-14.

PMID:
7587268
7.

Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.

Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.

Pediatrics. 2006 Jul;118(1):e76-84. Epub 2006 Jun 2.

PMID:
16751617
8.

Change in regional (somatic) near-infrared spectroscopy is not a useful indicator of clinically detectable low cardiac output in children after surgery for congenital heart defects.

Bhalala US, Nishisaki A, McQueen D, Bird GL, Morrison WE, Nadkarni VM, Nathan M, Starr JP.

Pediatr Crit Care Med. 2012 Sep;13(5):529-34. doi: 10.1097/PCC.0b013e3182389531.

PMID:
22596064
9.

Milrinone in advanced heart failure: dose and therapeutic monitor outside intensive care unit.

Charisopoulou D, Leaver N, Banner NR.

Angiology. 2014 Apr;65(4):343-9. doi: 10.1177/0003319713485808. Epub 2013 Apr 25.

PMID:
23620310
10.

Milrinone and low cardiac output following cardiac surgery in infants: is there a direct myocardial effect?

Duggal B, Pratap U, Slavik Z, Kaplanova J, Macrae D.

Pediatr Cardiol. 2005 Sep-Oct;26(5):642-5.

PMID:
16193374
12.

Disposition of milrinone in patients after cardiac surgery.

Das PA, Skoyles JR, Sherry KM, Peacock JE, Fox PA, Woolfrey SG.

Br J Anaesth. 1994 Apr;72(4):426-9.

PMID:
8155445
13.

Impact of empiric nesiritide or milrinone infusion on early postoperative recovery after Fontan surgery: a randomized, double-blind, placebo-controlled trial.

Costello JM, Dunbar-Masterson C, Allan CK, Gauvreau K, Newburger JW, McGowan FX Jr, Wessel DL, Mayer JE Jr, Salvin JW, Dionne RE, Laussen PC.

Circ Heart Fail. 2014 Jul;7(4):596-604. doi: 10.1161/CIRCHEARTFAILURE.113.001312. Epub 2014 Jun 6.

14.

Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.

Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL.

Circulation. 2003 Feb 25;107(7):996-1002.

15.

Slow induction of milrinone after coronary artery bypass grafting.

Shibata T, Suehiro S, Sasaki Y, Hosono M, Nishi S, Kinoshita H.

Ann Thorac Cardiovasc Surg. 2001 Feb;7(1):23-7.

PMID:
11343562
16.

Regional and central venous oxygen saturation monitoring following pediatric cardiac surgery: concordance and association with clinical variables.

McQuillen PS, Nishimoto MS, Bottrell CL, Fineman LD, Hamrick SE, Glidden DV, Azakie A, Adatia I, Miller SP.

Pediatr Crit Care Med. 2007 Mar;8(2):154-60.

PMID:
17273125
17.

Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial.

Momeni M, Rubay J, Matta A, Rennotte MT, Veyckemans F, Poncelet AJ, Clement de Clety S, Anslot C, Joomye R, Detaille T.

J Cardiothorac Vasc Anesth. 2011 Jun;25(3):419-24. doi: 10.1053/j.jvca.2010.07.004. Epub 2010 Sep 9.

PMID:
20829069
18.

Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial.

Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE.

Intensive Care Med. 2012 Jul;38(7):1198-204. doi: 10.1007/s00134-012-2564-6. Epub 2012 Apr 18.

PMID:
22527079
19.

Venoarterial PCO2 difference: a marker of postoperative cardiac output in children with congenital heart disease.

Furqan M, Hashmat F, Amanullah M, Khan M, Durani HK, Anwar-ul-Haque.

J Coll Physicians Surg Pak. 2009 Oct;19(10):640-3. doi: 10.2009/JCPSP.640643.

PMID:
19811716
20.

Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.

Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ.

Crit Care Med. 2007 Jan;35(1):252-9.

PMID:
17133188
Items per page

Supplemental Content

Write to the Help Desk